Encore Capital Group heads into the summer with an interesting tension: the Street is lifting price targets while insiders are quietly selling into strength.
Citizens' David Scharf raised his target to $115 this week — today, in fact — keeping his Market Outperform rating intact. That's the second lift from Scharf in six weeks; he moved from $90 to $108 after Q1 results in early May. Truist Securities followed that same post-earnings move with a bump to $105. The pattern is consistent: both firms remain bullish and have been ratcheting targets higher as the stock climbs. The consensus mean now rests near $113, roughly 36% above the current price of $82.98 — a meaningful implied return for what bulls characterise as a specialty finance name trading at a P/E of just 6.3x and EV/EBITDA around 8.2x. The EPS surprise factor score ranks in the 87th percentile, suggesting the company has a solid record of beating estimates. Bears counter that forward earnings growth looks thin — the 12-month forward EPS growth score ranks in just the 11th percentile — and that regulatory risk in the collections space and a potential economic slowdown could pressure cash collections.
The lending market tells a calm story. Short interest at 6.4% of the free float is meaningful but not extreme, and it edged up roughly 1% on the week — a gentle drift rather than a conviction-driven build. More telling is borrow availability: with availability running near 839%, there are roughly eight shares available to borrow for every one already shorted. That's well within the normal range and a notable loosening from the tighter readings seen in May, when availability dipped toward 615%. Cost to borrow has drifted down sharply — off about 12% on the month to under 0.4% — confirming there is no meaningful squeeze dynamic. Options positioning reinforces the neutral tone: the put/call ratio at 2.75 is actually slightly below its 20-day average, with a z-score of -1.4, meaning options traders are not pricing in incremental downside protection right now. Positioning as a whole looks stable rather than charged.
The insider picture is worth a flag. The General Counsel, Andrew Asch, made a cluster of sales between June 9 and June 10 totalling roughly $677,000, across several transactions at prices around $81–82. A division President, John Yung, sold 4,000 shares over the same two days for around $325,000. These are not enormous in absolute terms, and they follow the stock's steady climb from the $68 range in March. Net insider activity over the past 90 days is modestly positive at roughly $1.1 million, skewed by the March CEO sale — Ashish Masih sold 25,658 shares at $68.19 for about $1.75 million in a transaction that preceded the current leg higher. The recent cluster of sales near $82 is a natural profit-taking pattern after a 22% run from those March levels, but it does sit in contrast to the Street's continued upward target revisions.
The next scheduled earnings event falls on August 5. The most recent Q1 print on May 6 saw the stock drop 2.6% on the day and extend those losses to 6.4% over the following five sessions — a reminder that even when the Street is broadly constructive, the market has been skeptical of near-term delivery. Closest peer PRAA was essentially flat on the week at +0.7%, while more volatile consumer finance names like ENVA and ATLC gained 8% and 8.4% respectively — suggesting ECPG's muted weekly move of half a percent reflects its more defensive positioning within the group rather than any idiosyncratic drag.
The key dynamic to watch into August is whether the gap between the Street's target-price optimism and the market's post-earnings skepticism narrows — and whether insider selling at current levels accelerates as the stock approaches the $113 consensus target.
See the live data behind this article on ORTEX.
Open ECPG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
